NeoGenomics (NGN +8.6% to $3.40) prices an offering of 3.15M shares at $3 each, with the company selling 2.85M shares and a stockholder 300K. NeoGenomics expects to receive net proceeds of $7.8M, which it will use to pay debt and for general purposes. There's also a greenshoe option of 472,500 shares
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.